Skip to main content
Premium Trial:

Request an Annual Quote

Syzygy Biotech Nabs $100K Investment for PCR Reagent Development


This article has been corrected from a previous version to correct misinformation regarding the current name of Syzygy Biotech.

Syzygy Biotech, a Grand Rapids, Mich.-based PCR reagents shop, has received a $100,000 investment from the Michigan Pre-Seed Capital Fund, fund administrator Ann Arbor Spark said today.

Syzygy, which was formed under the name Seedus Biotech, manufactures low-cost reagents such as Taq polymerases and master mixes for use in DNA amplification.

According to its website, the company is also currently developing a high-fidelity polymerase that it claims combines Taq's ease of use with equal or greater replication accuracy.

Syzygy is one of several companies to have recently received investments totaling about $1.8 million from the Michigan Pre-Seed Capital Fund, an equity fund administered by Ann Arbor Spark that invests in technology-based companies to support business formation and acceleration.

Last month, Syzygy also won a $100,000 SmartZone award at the Great Lakes Entrepreneur's Quest business plan contest held at Michigan State University. That award was also funded through the Michigan Pre-Seed Capital Fund.

Filed under

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.